IMAX CORP (IMAX) Fundamental Analysis & Valuation

NYSE:IMAX • CA45245E1097

Current stock price

38.1 USD
-0.21 (-0.55%)
At close:
37.1989 USD
-0.9 (-2.37%)
After Hours:

This IMAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. IMAX Profitability Analysis

1.1 Basic Checks

  • IMAX had positive earnings in the past year.
  • IMAX had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
  • Each year in the past 5 years IMAX had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of IMAX (3.90%) is better than 82.50% of its industry peers.
  • IMAX has a Return On Equity of 10.32%. This is in the better half of the industry: IMAX outperforms 80.00% of its industry peers.
  • IMAX's Return On Invested Capital of 9.75% is amongst the best of the industry. IMAX outperforms 88.75% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for IMAX is in line with the industry average of 7.34%.
  • The 3 year average ROIC (7.16%) for IMAX is below the current ROIC(9.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.9%
ROE 10.32%
ROIC 9.75%
ROA(3y)3.38%
ROA(5y)0.97%
ROE(3y)9.43%
ROE(5y)2.68%
ROIC(3y)7.16%
ROIC(5y)4.6%
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • IMAX's Profit Margin of 8.50% is fine compared to the rest of the industry. IMAX outperforms 78.75% of its industry peers.
  • IMAX has a better Operating Margin (23.04%) than 93.75% of its industry peers.
  • In the last couple of years the Operating Margin of IMAX has grown nicely.
  • With a decent Gross Margin value of 60.02%, IMAX is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • IMAX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.04%
PM (TTM) 8.5%
GM 60.02%
OM growth 3Y103.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y30.77%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. IMAX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IMAX is still creating some value.
  • Compared to 1 year ago, IMAX has more shares outstanding
  • The number of shares outstanding for IMAX has been reduced compared to 5 years ago.
  • The debt/assets ratio for IMAX has been reduced compared to a year ago.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • IMAX has an Altman-Z score of 2.89. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • IMAX's Altman-Z score of 2.89 is fine compared to the rest of the industry. IMAX outperforms 77.50% of its industry peers.
  • The Debt to FCF ratio of IMAX is 2.45, which is a good value as it means it would take IMAX, 2.45 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.45, IMAX belongs to the best of the industry, outperforming 82.50% of the companies in the same industry.
  • A Debt/Equity ratio of 0.82 indicates that IMAX is somewhat dependend on debt financing.
  • The Debt to Equity ratio of IMAX (0.82) is worse than 60.00% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for IMAX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 2.45
Altman-Z 2.89
ROIC/WACC1.08
WACC9.02%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • IMAX has a Current Ratio of 2.34. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.34, IMAX is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • IMAX has a Quick Ratio of 2.08. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
  • IMAX has a Quick ratio of 2.08. This is in the better half of the industry: IMAX outperforms 77.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 2.08
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. IMAX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 51.58% over the past year.
  • IMAX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 174.00% yearly.
  • IMAX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.47%.
  • IMAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.53% yearly.
EPS 1Y (TTM)51.58%
EPS 3Y174%
EPS 5YN/A
EPS Q2Q%114.81%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y10.89%
Revenue growth 5Y24.53%
Sales Q2Q%35.11%

3.2 Future

  • Based on estimates for the next years, IMAX will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.86% on average per year.
  • The Revenue is expected to grow by 7.49% on average over the next years.
EPS Next Y19.65%
EPS Next 2Y18.1%
EPS Next 3Y16.79%
EPS Next 5Y17.86%
Revenue Next Year8.85%
Revenue Next 2Y8.19%
Revenue Next 3Y7.49%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. IMAX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 26.46, IMAX can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of IMAX indicates a rather cheap valuation: IMAX is cheaper than 83.75% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, IMAX is valued at the same level.
  • With a Price/Forward Earnings ratio of 22.11, IMAX is valued on the expensive side.
  • 80.00% of the companies in the same industry are more expensive than IMAX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of IMAX to the average of the S&P500 Index (23.84), we can say IMAX is valued inline with the index average.
Industry RankSector Rank
PE 26.46
Fwd PE 22.11
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 72.50% of the companies in the same industry are more expensive than IMAX, based on the Enterprise Value to EBITDA ratio.
  • IMAX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IMAX is cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.11
EV/EBITDA 14.23
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • IMAX has a very decent profitability rating, which may justify a higher PE ratio.
  • IMAX's earnings are expected to grow with 16.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y18.1%
EPS Next 3Y16.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IMAX Dividend Analysis

5.1 Amount

  • No dividends for IMAX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IMAX Fundamentals: All Metrics, Ratios and Statistics

IMAX CORP

NYSE:IMAX (3/13/2026, 8:04:00 PM)

After market: 37.1989 -0.9 (-2.37%)

38.1

-0.21 (-0.55%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners89.54%
Inst Owner Change-5.1%
Ins Owners19.16%
Ins Owner Change1.52%
Market Cap2.06B
Revenue(TTM)410.21M
Net Income(TTM)34.88M
Analysts82.22
Price Target45.22 (18.69%)
Short Float %14.67%
Short Ratio5.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.9%
Min EPS beat(2)20.72%
Max EPS beat(2)25.08%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)11.91%
Max EPS beat(4)25.08%
EPS beat(8)7
Avg EPS beat(8)39.29%
EPS beat(12)11
Avg EPS beat(12)56.86%
EPS beat(16)11
Avg EPS beat(16)9.47%
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)1.69%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-1.46%
Max Revenue beat(4)1.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.13%
Revenue beat(12)6
Avg Revenue beat(12)1.38%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)0%
PT rev (3m)13.68%
EPS NQ rev (1m)-17.66%
EPS NQ rev (3m)-16.7%
EPS NY rev (1m)4.14%
EPS NY rev (3m)10.12%
Revenue NQ rev (1m)-5.82%
Revenue NQ rev (3m)-5.97%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)2.45%
Valuation
Industry RankSector Rank
PE 26.46
Fwd PE 22.11
P/S 5.01
P/FCF 18.11
P/OCF 16.19
P/B 6.09
P/tB 8.43
EV/EBITDA 14.23
EPS(TTM)1.44
EY3.78%
EPS(NY)1.72
Fwd EY4.52%
FCF(TTM)2.1
FCFY5.52%
OCF(TTM)2.35
OCFY6.18%
SpS7.6
BVpS6.26
TBVpS4.52
PEG (NY)1.35
PEG (5Y)N/A
Graham Number14.24
Profitability
Industry RankSector Rank
ROA 3.9%
ROE 10.32%
ROCE 12.28%
ROIC 9.75%
ROICexc 12.13%
ROICexgc 18.37%
OM 23.04%
PM (TTM) 8.5%
GM 60.02%
FCFM 27.69%
ROA(3y)3.38%
ROA(5y)0.97%
ROE(3y)9.43%
ROE(5y)2.68%
ROIC(3y)7.16%
ROIC(5y)4.6%
ROICexc(3y)8.52%
ROICexc(5y)5.48%
ROICexgc(3y)12.64%
ROICexgc(5y)8.08%
ROCE(3y)9.03%
ROCE(5y)5.8%
ROICexgc growth 3Y130.34%
ROICexgc growth 5YN/A
ROICexc growth 3Y121.43%
ROICexc growth 5YN/A
OM growth 3Y103.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.9%
GM growth 5Y30.77%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 2.45
Debt/EBITDA 1.81
Cap/Depr 22.57%
Cap/Sales 3.29%
Interest Coverage 19.38
Cash Conversion 82.36%
Profit Quality 325.66%
Current Ratio 2.34
Quick Ratio 2.08
Altman-Z 2.89
F-Score8
WACC9.02%
ROIC/WACC1.08
Cap/Depr(3y)24.91%
Cap/Depr(5y)22.45%
Cap/Sales(3y)4.01%
Cap/Sales(5y)3.86%
Profit Quality(3y)235.18%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.58%
EPS 3Y174%
EPS 5YN/A
EPS Q2Q%114.81%
EPS Next Y19.65%
EPS Next 2Y18.1%
EPS Next 3Y16.79%
EPS Next 5Y17.86%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y10.89%
Revenue growth 5Y24.53%
Sales Q2Q%35.11%
Revenue Next Year8.85%
Revenue Next 2Y8.19%
Revenue Next 3Y7.49%
Revenue Next 5YN/A
EBIT growth 1Y97.55%
EBIT growth 3Y125.88%
EBIT growth 5YN/A
EBIT Next Year115.44%
EBIT Next 3Y38.8%
EBIT Next 5Y25.01%
FCF growth 1Y110.48%
FCF growth 3Y193.33%
FCF growth 5YN/A
OCF growth 1Y79.38%
OCF growth 3Y94.39%
OCF growth 5YN/A

IMAX CORP / IMAX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IMAX CORP?

ChartMill assigns a fundamental rating of 6 / 10 to IMAX.


Can you provide the valuation status for IMAX CORP?

ChartMill assigns a valuation rating of 5 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 7 / 10.


What is the earnings growth outlook for IMAX CORP?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 19.65% in the next year.